Otsuka
Go Search
  • Home
  • Our Companies
    • Otsuka America Pharmaceutical, Inc. (OAPI)
    • Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
    • Otsuka Maryland Medicinal Laboratories, Inc. (OMML)
  • Our Culture
  • Products
  • Resources
    • Patient Assistance
    • Sponsorships and Grants
    • Returned Goods Policy for U.S.
    • Authorized Distributor of Record
  • Careers
  • Resources
    • Patient Assistance
    • Sponsorships and Grants
    • Returned Goods Policy for U.S.
    • Authorized Distributor of Record
Patient Assistance
Some patients may be eligible to receive assistance paying for some products. Use the information below to receive more information on our product patient assistance programs.

For ABILIFY® (aripiprazole)1 Patient Assistance, please call (800) 736-0003 or visit www.bmspaf.org.

1 Please see FULL PRESCRIBING INFORMATION including Boxed WARNING for ABILIFY.
 

  • Site Map
  • Go to Our Worldwide Site
  • Contact Us
  • FAQs
  • Privacy Policy
  • Terms of Use

OAPI, OPDC and OMML are subsidiaries of Otsuka America, Inc. (OAI), a holding company established in the U.S. in 1989.
OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd.